Caroline Y. Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caroline Y. Jones has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Björn Oskarsson
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
2 shared publications - Casey N. Cook
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States
2 shared publications - Dennis W. Dickson
Department of Neuroscience, Mayo Clinic, Jacksonville, USA
2 shared publications Giulia del Rosso
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
2 shared publicationsJimei Tong
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
2 shared publications- Karen Jansen-West
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
2 shared publications
Latest Publications
- 7 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6615) , 94-99
Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration
Frontotemporal dementia and amyotrophic lateral sclerosis (FTD-ALS) are associated with both a repeat expansion in the C9orf72 gene and mutations in the TANK-binding kinase 1 ( TBK1 ) gene. We found that TBK1 is phosphorylated in response to C9orf72 poly(Gly-Ala) [poly(GA)] aggregation and sequestered into inclusions, which leads to a loss of TBK1 activity and contributes to neurodegeneration. When we reduced TBK1 activity using a TBK1-R228H (Arg 228 →His) mutation in mice, poly(GA)-induced phenotypes were exacerbated. These phenotypes included an increase in TAR DNA binding protein 43 (TDP-43) pathology and the accumulation of defective endosomes in poly(GA)-positive neurons. Inhibiting the endosomal pathway induced TDP-43 aggregation, which highlights the importance of this pathway and TBK1 activity in pathogenesis. This interplay between C9orf72 , TBK1 , and TDP-43 connects three different facets of FTD-ALS into one coherent pathway.
- 7 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6615) , 94-99
Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration
Frontotemporal dementia and amyotrophic lateral sclerosis (FTD-ALS) are associated with both a repeat expansion in the C9orf72 gene and mutations in the TANK-binding kinase 1 ( TBK1 ) gene. We found that TBK1 is phosphorylated in response to C9orf72 poly(Gly-Ala) [poly(GA)] aggregation and sequestered into inclusions, which leads to a loss of TBK1 activity and contributes to neurodegeneration. When we reduced TBK1 activity using a TBK1-R228H (Arg 228 →His) mutation in mice, poly(GA)-induced phenotypes were exacerbated. These phenotypes included an increase in TAR DNA binding protein 43 (TDP-43) pathology and the accumulation of defective endosomes in poly(GA)-positive neurons. Inhibiting the endosomal pathway induced TDP-43 aggregation, which highlights the importance of this pathway and TBK1 activity in pathogenesis. This interplay between C9orf72 , TBK1 , and TDP-43 connects three different facets of FTD-ALS into one coherent pathway.
- Open Access
- 12 January 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 809942
HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS
The aberrant translation of a repeat expansion in chromosome 9 open reading frame 72 (C9orf72), the most common cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), results in the accumulation of toxic dipeptide repeat (DPR) proteins in the central nervous system We have found that, among the sense DPR proteins, HDAC6 specifically interacts with the poly (GA) and co-localizes with inclusions in both patient tissue and a mouse model of this disease (c9FTD/ALS). Overexpression of HDAC6 increased poly (GA) levels in cultured cells independently of HDAC6 deacetylase activity, suggesting that HDAC6 can modulate poly (GA) pathology through a mechanism that depends upon their physical interaction. Moreover, decreasing HDAC6 expression by stereotaxic injection of antisense oligonucleotides significantly reduced the number of poly (GA) inclusions in c9FTD/ALS mice. These findings suggest that pharmacologically reducing HDAC6 levels could be of therapeutic value in c9FTD/ALS.
- 12 January 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 809942
Open AccessHDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS
The aberrant translation of a repeat expansion in chromosome 9 open reading frame 72 (C9orf72), the most common cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), results in the accumulation of toxic dipeptide repeat (DPR) proteins in the central nervous system We have found that, among the sense DPR proteins, HDAC6 specifically interacts with the poly (GA) and co-localizes with inclusions in both patient tissue and a mouse model of this disease (c9FTD/ALS). Overexpression of HDAC6 increased poly (GA) levels in cultured cells independently of HDAC6 deacetylase activity, suggesting that HDAC6 can modulate poly (GA) pathology through a mechanism that depends upon their physical interaction. Moreover, decreasing HDAC6 expression by stereotaxic injection of antisense oligonucleotides significantly reduced the number of poly (GA) inclusions in c9FTD/ALS mice. These findings suggest that pharmacologically reducing HDAC6 levels could be of therapeutic value in c9FTD/ALS.